QNRX Quoin Pharmaceuticals, Ltd.: institutional ownership and insider trading
20 funds reported holding $6.30M of Quoin Pharmaceuticals, Ltd. in their latest 13F filings; in Q2 2026 funds net bought $555K, with 1 new positions and 3 funds selling out; over the last 12 months insiders bought $280K and sold $0 on the open market.
QNRX revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$5.37M
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.00M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$4.34M
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.95M
Famous investors holding QNRX
- Izzy Englander (Millennium Management): $544K, 0.0% of the portfolio
Largest institutional holders of QNRX
- Dauntless Investment Group, LLC — $1.04M
- Ikarian Capital, LLC — $1.02M
- Stonepine Capital Management, LLC — $966K
- MILLENNIUM MANAGEMENT LLC — $544K
- SummitTX Capital, L.P. — $485K
- Woodline Partners LP — $370K
- Aberdeen Group plc — $363K
- Soleus Capital Management, L.P. — $352K
- AIGH Capital Management LLC — $339K
- BOOTHBAY FUND MANAGEMENT, LLC — $290K
Recent QNRX insider trades
- Aug 31, 2026: Culverwell Anthony James bought 6,146 shares ($30.0K)
- Aug 31, 2026: Lawlor Sally Bridget bought 10,244 shares ($50.0K)
- Aug 31, 2026: Myers Michael bought 20,490 shares ($100.0K)
- Aug 31, 2026: Carter Denise P. bought 20,490 shares ($100.0K)
5%+ owners
- Stonepine Capital Management, LLC: 10.0% (Schedule 13G/A, filed May 15, 2026)
- Integrated Core Strategies (US) LLC: 5.5% (Schedule 13G, filed Jun 2, 2026)
Who owns the most QNRX stock?
The largest institutional holders of Quoin Pharmaceuticals, Ltd. in the latest 13F filings are Dauntless Investment Group, LLC ($1.04M), Ikarian Capital, LLC ($1.02M), Stonepine Capital Management, LLC ($966K).
Are insiders buying or selling QNRX?
Over the last 12 months insiders bought $280K and sold $0 of Quoin Pharmaceuticals, Ltd. stock on the open market (SEC Form 4).
Which famous investors own QNRX?
Izzy Englander.